Vassilis Nidris
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vassilis Nidris has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Agostinho Carvalho
Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho , Braga
3 shared publications Elias Drakos
School of Medicine, University of Crete
3 shared publicationsEvangelia Intze
University of Crete
3 shared publications- Georgios Chamilos
Institute of Molecular Biology and Biotechnology, FORTH, Hellas
3 shared publications - Ioannis Morianos
School of Medicine, University of Crete, Voutes, Heraklion, Greece
3 shared publications Amy Spallone
Department of Infectious Diseases, Infection Control and Employee Health, University of Texas MD Anderson Cancer Center, Houston, USA
2 shared publications
Latest Publications
- Open Access
- 4 March 2026
- Published by Springer Nature in Research Square
Fungal melanin induces host lipid defense by rewiring macrophage metabolism
Alveolar macrophages (AMs) employ specialized immunometabolic programs to counteract virulence mechanisms of airborne pathogens and confer host protection1. Mucormycosis is a life-threatening respiratory fungal infection that predominantly affects patients with metabolic abnormalities, especially diabetic ketoacidosis (DKA) 2, through poorly defined mechanisms. Unlike other fungi, Mucorales induce phagosome maturation arrest in AMs through persistent surface expression of melanin3,4, yet the host defense mechanisms that restrict fungal growth remain uncharacterized. Herein, we found that phagocytosis of Mucorales spores triggers the selective recruitment of Lipid Droplets (LDs) to the phagosome, through metabolic reprograming of AM metabolism toward oxidative phosphorylation (OXPHOS). Ca2+ sequestration by fungal melanin triggers this immunometabolic response in AMs by modulating mitochondria dynamics. LD targeting results in robust accumulation of host free fatty acids (FFAs) within intracellular Mucorales spores, leading to rapid mitochondrial fragmentation, suppression of aerobic glycolysis and fungal growth arrest. In DKA, nuclear stabilization of HIF1 inhibits mitochondrial function and OXPHOS-dependent LD targeting to the phagosome to promote fungal disease. Pharmacological inhibition or conditional deletion of HIF1 in AMs restores OXPHOS and protects against mucormycosis. Collectively, our findings define a melanin-driven immunometabolic defense program and reveal host and fungal metabolic vulnerabilities with important implications in pathogenesis and treatment of mucormycosis.
- 4 March 2026
- Published by Springer Nature in Research Square
Open AccessFungal melanin induces host lipid defense by rewiring macrophage metabolism
Alveolar macrophages (AMs) employ specialized immunometabolic programs to counteract virulence mechanisms of airborne pathogens and confer host protection1. Mucormycosis is a life-threatening respiratory fungal infection that predominantly affects patients with metabolic abnormalities, especially diabetic ketoacidosis (DKA) 2, through poorly defined mechanisms. Unlike other fungi, Mucorales induce phagosome maturation arrest in AMs through persistent surface expression of melanin3,4, yet the host defense mechanisms that restrict fungal growth remain uncharacterized. Herein, we found that phagocytosis of Mucorales spores triggers the selective recruitment of Lipid Droplets (LDs) to the phagosome, through metabolic reprograming of AM metabolism toward oxidative phosphorylation (OXPHOS). Ca2+ sequestration by fungal melanin triggers this immunometabolic response in AMs by modulating mitochondria dynamics. LD targeting results in robust accumulation of host free fatty acids (FFAs) within intracellular Mucorales spores, leading to rapid mitochondrial fragmentation, suppression of aerobic glycolysis and fungal growth arrest. In DKA, nuclear stabilization of HIF1 inhibits mitochondrial function and OXPHOS-dependent LD targeting to the phagosome to promote fungal disease. Pharmacological inhibition or conditional deletion of HIF1 in AMs restores OXPHOS and protects against mucormycosis. Collectively, our findings define a melanin-driven immunometabolic defense program and reveal host and fungal metabolic vulnerabilities with important implications in pathogenesis and treatment of mucormycosis.
- Open Access
- 2 February 2026
- Published by Springer Nature in Nature
- Vol. 650 (8102) , E11
Author Correction: Albumin orchestrates a natural host defence mechanism against mucormycosis
- 2 February 2026
- Published by Springer Nature in Nature
- Vol. 650 (8102) , E11
Open AccessAuthor Correction: Albumin orchestrates a natural host defence mechanism against mucormycosis
- Top Cited PapersOpen Access
- 7 January 2026
- Published by Springer Nature in Nature
- Vol. 649 (8097) , 693-702
Albumin orchestrates a natural host defence mechanism against mucormycosis
Mucormycosis is an emerging, life-threatening human infection caused by Mucorales fungi1,2,3. Metabolic disorders uniquely predispose an ever-expanding group of patients to mucormycosis through poorly understood mechanisms1,2,4,5, suggesting that uncharacterized host metabolic effectors may confer protective immunity against this infection. Here we uncover a master regulatory role of albumin in host defence against Mucorales through the modulation of fungal pathogenicity. Our initial studies identified severe hypoalb uminaemia as a prominent metabolic abnormality and an independent biomarker of poor mucormycosis outcome across three distinct cohorts of patients with mucormycosis. Notably, purified albumin selectively inhibits Mucorales growth among a range of pathogens, and albumin-deficient mice display susceptibility specifically to mucormycosis. The antifungal activity of albumin is mediated by the release of bound free fatty acids (FFAs). Albumin prevents FFA oxidation, which otherwise abolishes their antifungal properties, and sera from patients with mucormycosis display high levels of oxidized FFAs. Physiologically, albumin-bound FFAs suppress the expression of key virulence factors by inhibiting protein synthesis, the reby rendering Mucorales avirulent in vivo. Overall, we identify a host defence mechanism that directs the pathogen to suppress its pathogenicity program in response to unfavourable metabolic cues regulated by albumin. These findings have major implications for the pathogenesis and management of mucormycosis.
- 7 January 2026
- Published by Springer Nature in Nature
- Vol. 649 (8097) , 693-702
Top Cited PapersOpen AccessAlbumin orchestrates a natural host defence mechanism against mucormycosis
Mucormycosis is an emerging, life-threatening human infection caused by Mucorales fungi1,2,3. Metabolic disorders uniquely predispose an ever-expanding group of patients to mucormycosis through poorly understood mechanisms1,2,4,5, suggesting that uncharacterized host metabolic effectors may confer protective immunity against this infection. Here we uncover a master regulatory role of albumin in host defence against Mucorales through the modulation of fungal pathogenicity. Our initial studies identified severe hypoalb uminaemia as a prominent metabolic abnormality and an independent biomarker of poor mucormycosis outcome across three distinct cohorts of patients with mucormycosis. Notably, purified albumin selectively inhibits Mucorales growth among a range of pathogens, and albumin-deficient mice display susceptibility specifically to mucormycosis. The antifungal activity of albumin is mediated by the release of bound free fatty acids (FFAs). Albumin prevents FFA oxidation, which otherwise abolishes their antifungal properties, and sera from patients with mucormycosis display high levels of oxidized FFAs. Physiologically, albumin-bound FFAs suppress the expression of key virulence factors by inhibiting protein synthesis, the reby rendering Mucorales avirulent in vivo. Overall, we identify a host defence mechanism that directs the pathogen to suppress its pathogenicity program in response to unfavourable metabolic cues regulated by albumin. These findings have major implications for the pathogenesis and management of mucormycosis.